Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Suvorexant in Patients with Insomnia: Pooled Analyses of Three-Month Data from Phase-3 Randomized Controlled Clinical Trials
W. Joseph Herring, Kathleen M. Connor, Ellen Snyder, et al.
Journal of Clinical Sleep Medicine (2016) Vol. 12, Iss. 09, pp. 1215-1225
Open Access | Times Cited: 71

Showing 1-25 of 71 citing articles:

Comparison of Lemborexant With Placebo and Zolpidem Tartrate Extended Release for the Treatment of Older Adults With Insomnia Disorder
Russell Rosenberg, Patricia Murphy, Gary Zammit, et al.
JAMA Network Open (2019) Vol. 2, Iss. 12, pp. e1918254-e1918254
Open Access | Times Cited: 340
Polysomnographic assessment of suvorexant in patients with probable Alzheimer's disease dementia and insomnia: a randomized trial
W. Joseph Herring, Paulette Ceesay, Ellen Snyder, et al.
Alzheimer s & Dementia (2020) Vol. 16, Iss. 3, pp. 541-551
Open Access | Times Cited: 138
The 2023 nonhormone therapy position statement of The North American Menopause Society
Chrisandra Shufelt, Vivien Brown, Janet S. Carpenter, et al.
Menopause The Journal of The North American Menopause Society (2023) Vol. 30, Iss. 6, pp. 573-590
Closed Access | Times Cited: 102
Hypocretins (orexins): The ultimate translational neuropeptides
Laura H. Jacobson, Daniël Hoyer, Luı́s de Lecea
Journal of Internal Medicine (2022) Vol. 291, Iss. 5, pp. 533-556
Closed Access | Times Cited: 71
Orexin Receptor Antagonists as Emerging Treatments for Psychiatric Disorders
Ying Han, Kai Yuan, Yongbo Zheng, et al.
Neuroscience Bulletin (2019) Vol. 36, Iss. 4, pp. 432-448
Open Access | Times Cited: 77
The orexin story and orexin receptor antagonists for the treatment of insomnia
Clemens Muehlan, Catherine Roch, Cédric Vaillant, et al.
Journal of Sleep Research (2023) Vol. 32, Iss. 6
Open Access | Times Cited: 39
Targeting Orexin Receptors for the Treatment of Insomnia: From Physiological Mechanisms to Current Clinical Evidence and Recommendations
Maria P. Mogavero, Alessandro Silvani, Giuseppe Lanza, et al.
Nature and Science of Sleep (2023) Vol. Volume 15, pp. 17-38
Open Access | Times Cited: 23
Non-Opioid Neurotransmitter Systems that Contribute to the Opioid Withdrawal Syndrome: A Review of Preclinical and Human Evidence
Kelly E. Dunn, Andrew S. Huhn, Cecilia L. Bergeria, et al.
Journal of Pharmacology and Experimental Therapeutics (2019) Vol. 371, Iss. 2, pp. 422-452
Open Access | Times Cited: 56
Advances in the Treatment of Chronic Insomnia: A Narrative Review of New Nonpharmacologic and Pharmacologic Therapies
Russell Rosenberg, Leslie Citrome, Christopher L. Drake
Neuropsychiatric Disease and Treatment (2021) Vol. Volume 17, pp. 2549-2566
Open Access | Times Cited: 47
Prescription Drugs Used in Insomnia
Sylvie Dujardin, Angelique Pijpers, Dirk Pevernagie
Sleep Medicine Clinics (2020) Vol. 15, Iss. 2, pp. 133-145
Closed Access | Times Cited: 39
Seltorexant for major depressive disorder
K.L. Valentino, Kayla M. Teopiz, Sabrina Wong, et al.
Expert Opinion on Emerging Drugs (2025)
Closed Access
Orexin receptor antagonists for the treatment of insomnia and potential treatment of other neuropsychiatric indications
W. Joseph Herring, Thomas Roth, Andrew D. Krystal, et al.
Journal of Sleep Research (2018) Vol. 28, Iss. 2
Closed Access | Times Cited: 44
Insomnia in patients with schizophrenia: current understanding and treatment options
Ian H. Robertson, Amy Cheung, Xiaoduo Fan
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2019) Vol. 92, pp. 235-242
Closed Access | Times Cited: 42
Orexin dual receptor antagonists, zolpidem, zopiclone, eszopiclone, and cognitive research: A comprehensive dose-response meta-analysis
Mengzhen Zhou, Jiyou Tang, Shasha Li, et al.
Frontiers in Human Neuroscience (2023) Vol. 16
Open Access | Times Cited: 11
Hypothalamic Dysfunction and Multiple Sclerosis: Implications for Fatigue and Weight Dysregulation
Kevin G. Burfeind, Vijayshree Yadav, Daniel L. Marks
Current Neurology and Neuroscience Reports (2016) Vol. 16, Iss. 11
Open Access | Times Cited: 35
Prescription Drugs Used in Insomnia
Sylvie Dujardin, Angelique Pijpers, Dirk Pevernagie
Sleep Medicine Clinics (2018) Vol. 13, Iss. 2, pp. 169-182
Closed Access | Times Cited: 35
Hypnotics with novel modes of action
Daniël Hoyer, Andrew G. Allen, Laura H. Jacobson
British Journal of Clinical Pharmacology (2019) Vol. 86, Iss. 2, pp. 244-249
Open Access | Times Cited: 33
Suvorexant for the prevention of delirium
Shu Xu, Yuanyuan Cui, Jinhua Shen, et al.
Medicine (2020) Vol. 99, Iss. 30, pp. e21043-e21043
Open Access | Times Cited: 29
The Treatment of Sleep Dysfunction in Neurodegenerative Disorders
Zanna Voysey, Roger A. Barker, Alpár S. Lázár
Neurotherapeutics (2020) Vol. 18, Iss. 1, pp. 202-216
Open Access | Times Cited: 29
Orexin Receptor Antagonists in the Treatment of Depression: A Leading Article Summarising Pre-clinical and Clinical Studies
Harry Fagan, Edward G. Jones, David S. Baldwin
CNS Drugs (2022) Vol. 37, Iss. 1, pp. 1-12
Closed Access | Times Cited: 17
Impact of lemborexant treatment on insomnia severity: analyses from a 12-month study of adults with insomnia disorder
Thomas Roth, Russell Rosenberg, Charles M. Morin, et al.
Sleep Medicine (2022) Vol. 90, pp. 249-257
Open Access | Times Cited: 16
Sleep Dysfunction in Huntington’s Disease: Impacts of Current Medications and Prospects for Treatment
Natalia E. Owen, Roger A. Barker, Zanna Voysey
Journal of Huntington s Disease (2023) Vol. 12, Iss. 2, pp. 149-161
Open Access | Times Cited: 9
Effects of suvorexant on the Insomnia Severity Index in patients with insomnia: analysis of pooled phase 3 data
W. Joseph Herring, Kathryn M. Connor, Ellen Snyder, et al.
Sleep Medicine (2018) Vol. 56, pp. 219-223
Closed Access | Times Cited: 30
Insight Into Reduction of Wakefulness by Suvorexant in Patients With Insomnia: Analysis of Wake Bouts
Vladimir Svetnik, Ellen Snyder, Peining Tao, et al.
SLEEP (2017) Vol. 41, Iss. 1
Open Access | Times Cited: 28
Orexins, Sleep, and Blood Pressure
Mariusz Siemiński, Jacek Szypenbejl, Eemil Partinen
Current Hypertension Reports (2018) Vol. 20, Iss. 9
Open Access | Times Cited: 25
Page 1 - Next Page

Scroll to top